MAP

Welcome to the Brand page for “MAP”, which is offered here for Pharmaceutical products for use in the treatment of central nervous system and neurological diseases and disorders, migraines and headaches, pain; drug delivery devices, inhalers containing pre-filled drug cartridges which deliver medication in liquid form via the pulmonary route, either directly to the lungs or for absorption and delivery in systemic circulation for use in the treatment of central nervous system and neurological diseases and disorders, migraines and headaches, pain;medical apparatus and units for dosage, drug delivery devices;pharmaceutical research and development; research and development of pharmaceutical preparations for the treatment of central nervous system and neurological diseases and disorders, migraines and headaches, pain; research and development of drug delivery devices, both with and without pre-filled drug cartridges, for delivery of medication via the pulmonary route; medical and scientific research, conducting clinical trials;.

Its status is currently believed to be active. Its class is unavailable. “MAP” is believed to be currently owned by “ALLERGAN, INC.”